Dr. Piper Meyer-Kalos, PhD

Claim this profile
Studies Schizophrenia
Studies Psychosis
1 reported clinical trial
3 drugs studied

Clinical Trials Piper Meyer-Kalos, PhD is currently running

Image of trial facility.

Cognitive + Motivational Enhancement

for Early Psychosis

The purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. We will recruit participants who are receiving care for early psychosis from clinics across the United States. We will compare outcomes from participants who receive treatment at coordinated specialty care (CSC) early psychosis clinics to those that receive standard community care. A qualifying CSC program will provide comprehensive clinical services such as psychotherapy, medication management, psychoeducation, and work or education support. This study will be conducted remotely, and participants can participate at home with their own electronic devices. The aim of this study is to investigate a well-defined 12-week mobile intervention program specifically designed to target cognitive functioning and motivated behavior for individuals with early psychosis. Participants will complete a screening interview which will include diagnosis and symptom ratings, neurocognitive assessment, and self-reports of symptoms, behavior, and functioning. Then participants will be randomized to receive the 12-week mobile intervention, or an active control of treatment as usual. The investigators will test for differences in the clinical trajectories after training, and at two follow up appointments at 6 and 12 months post-training.
Recruiting1 award N/A

More about Piper Meyer-Kalos, PhD

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Piper Meyer-Kalos, PhD has experience with
  • Cognitive And Social Cognitive Training
  • Early Psychosis Coordinated Specialty Care
  • Personalized Real-Time Intervention For Motivational Enhancement (PRIME) App

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Piper Meyer-Kalos, PhD specialize in?
Piper Meyer-Kalos, PhD focuses on Schizophrenia and Psychosis. In particular, much of their work with Schizophrenia has involved treating patients, or patients who are undergoing treatment.
Is Piper Meyer-Kalos, PhD currently recruiting for clinical trials?
Yes, Piper Meyer-Kalos, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Piper Meyer-Kalos, PhD has studied deeply?
Yes, Piper Meyer-Kalos, PhD has studied treatments such as Cognitive and Social Cognitive Training, Early Psychosis Coordinated Specialty Care, Personalized Real-Time Intervention for Motivational Enhancement (PRIME) App.
What is the best way to schedule an appointment with Piper Meyer-Kalos, PhD?
Apply for one of the trials that Piper Meyer-Kalos, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security